Virtual Library

Start Your Search

M. Paz Fernández

Author of

  • +

    OA05 - Increasing the Impact of Nursing and Allied Health Professional Interventions in Lung Cancer Care (ID 130)

    • Event: WCLC 2019
    • Type: Oral Session
    • Track: Nursing and Allied Professionals
    • Presentations: 1
    • Now Available
    • +

      OA05.06 - Nursing Intervention on Immuno-Related Adverse Events in Lung Cancer Patients (Now Available) (ID 2135)

      15:15 - 16:45  |  Author(s): M. Paz Fernández

      • Abstract
      • Presentation
      • Slides


      New treatment of immunotherapy permits to stimulate the patient’s immune responses against cancer. That it supposes a new strategy for melanoma, renal and lung cancers. Although, is different than Chemotherapy’s toxicity, the effect on tissues and organs are systemic and can be dealing to unpredictable side-effects that should be detected and treated as soon as possible. Nurses are vital to manage toxicity related to immunotherapy & educate and to provide patient’s with best education.

      Our objetive is to describe lung cancer clinical nurses specialists’ role on the management of toxicities related to immunotherapy in lung cancer patients. How is the control and follow–up for those patients


      In 2018, a cross-sectional study was conducted with lung cancer patients receiving immunotherapy at the Lung Functional Unit of Catalan Institute of Oncology, hospital Duran I Reynals in Barcelona-Spain. The variables included were socio-demographic profile, the clinical were; tumour histological, toxicities prevalence and severity and finally variables from the roles and references made by nurses. A descriptive analysis of prevalence was performed with type of toxicities and patient characteristics.


      New patients receiving immunotherapy were 69 and the most common toxicities were; asthenia (82.5%), skin toxicity (35.5%), Pneumonitis (22.5%), colitis (20%), arthralgia (12.5%), endocrine toxicity (12.5%), emesis (10%), vascular (7.5%), gastritis (5%), hepatic (5%), renal (5%) & neurologic (5%). Attending grading severity, it was GI-GII, both were controlled by nurses, GIII and GIV required specialists, hospitalization and other professionals. Nurses visited 95% of the patients previously to initiate their treatments, attended 128 phone calls and in 111 patients they realised the follow-up and control. From total a 50% need emergency services and finally got hospitalization in 30% of them.


      Grades I and II are the most common toxicity. Nurses were in charge for patient education, providing careful information to patients, family members and caregivers, along the whole process. This role is vital to get better and earlier control on the side-effects, higher satisfaction and to facilitate the multidisciplinary team-working dynamic.

      Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.